More Americans have received at least 1 dose of Covid vaccine than tested positive

More Americans have received at least one dose of a Covid-19 vaccine than tested positive for the virus, an early but hopeful milestone in the race to end the pandemic.

According to data collected by the Bloomberg Vaccine Tracker, 26.5 million Americans had received one or both doses of the current vaccines as of Monday afternoon. Since the first American patient tested positive outside of Seattle a year ago, there are 26.2 million people in the country have tested positive for the disease, and 441,000 have died, according to data from Johns Hopkins University.

According to data collected by Bloomberg, the US is delivering injections faster than any country in the world every day, at about 1.35 million doses per day. While the rollout stumbled at first, in the six weeks since the first shots were fired in the arms, nearly 7.8% of Americans have received one or more doses and 1.8% have been fully vaccinated.

“It’s worth noting that today, for the first time, the data shows that more people have been vaccinated than reported as newly diagnosed cases,” said Paula Cannon, professor of microbiology at the University of Southern California’s Keck School of Medicine. ‘That’s worth celebrating. I am all for that victory. “

covid-vaccine-tracker-worldwide-distribution-inline

Only a few other countries have passed that milestone: Israel, the UK and the UAE beat the US days or weeks ago for tending to have more vaccinations than cases.

After a holiday spate in US cases, officials at the Center for Disease Control and Prevention are calling for the summit, though that’s likely due to behavioral changes and still no widespread impact from the vaccine. New Covid-19 cases, hospitalizations and emergency room visits are beginning to decline, said Jay Butler, the deputy director of the Infectious Diseases Bureau.

“While these trends are encouraging, I would like to emphasize that the numbers are still high nationally, and they are as high as at any point during the pandemic. until this point, ”he said at a Friday briefing hosted by the Infectious Diseases Society of America. “If this pandemic were a stock, we might want to sell.”

The virus can still roar, especially if variants emerging in South Africa and elsewhere emerge. Studies suggest that vaccines, especially the newer injections from Johnson & Johnson and Novavax Inc., are less potent against that species and at least one other.

.Source